These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7150905)

  • 41. [Systematic and local reactions during phlebography of the leg with special reference to postphlebographic complications. Randomized, prospective, intraindividual double-blind study of iopamidol and ioxithalamate (250 mg I/ml) using the 125I-fibrinogen test: II].
    Hagen B
    Radiologe; 1985 Jun; 25(6):260-4. PubMed ID: 3895289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Myelography with water-soluble contrast media in the diagnosis of space-occupying spinal lesions].
    Schmidt RC
    Rontgenpraxis; 1982 May; 35(5):166-73. PubMed ID: 7089723
    [No Abstract]   [Full Text] [Related]  

  • 43. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microscopic effects of meglumine iothalamate. Ventriculography in canines.
    Weems TD; Cashion EL; Cunningham DL
    Neuroradiology; 1977 May; 13(3):151-4. PubMed ID: 301255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [1st trials of a new contrast medium, iopamidol, in the study of the spinal canal].
    Bories J; Chiras J; Drouineau J
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):789-92. PubMed ID: 6670841
    [No Abstract]   [Full Text] [Related]  

  • 46. [Renal contrast radiography study in hypertensive patients: comparison of the nephrotoxicity of ionic and non-ionic contrast media].
    Mannella P; Tataranni G; Benea G; Logallo G; Farinelli A
    Radiol Med; 1983 Jun; 69(6):422-5. PubMed ID: 6665240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thrombosis of the superior longitudinal sinus after sacculoradiculography with iopamidol].
    Glowinski J; Breuillard P; Delafolie A; Redondo A
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183. PubMed ID: 3704532
    [No Abstract]   [Full Text] [Related]  

  • 48. [Accidents caused by contrast media used in uro-angiography].
    Peter JD
    Anesth Analg (Paris); 1977; 34(5):1029-37. PubMed ID: 77647
    [No Abstract]   [Full Text] [Related]  

  • 49. Release of serotonin from human platelets in vitro by radiographic contrast media.
    Ring J; Sovak M
    Invest Radiol; 1981; 16(3):245-8. PubMed ID: 7053228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The old and the new: a study of five contrast media for urography.
    Davies P; Panto PN; Buckley J; Richardson RE
    Br J Radiol; 1985 Jul; 58(691):593-7. PubMed ID: 3893610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of blood-brain barrier disruption in the rabbit following intracarotid iopamidol and methylglucamine iothalamate.
    Wycherley AG; Wilcox J; Sage MR
    Australas Radiol; 1984 Nov; 28(4):294-6. PubMed ID: 6535564
    [No Abstract]   [Full Text] [Related]  

  • 52. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of a non-ionic water-soluble contrast medium in ascending phlebography].
    Caramanico L; Di Zitti L; Farrocco G; Bocchetti T; Alessi G; Borghese M
    Minerva Cardioangiol; 1986 May; 34(5):349-51. PubMed ID: 3748421
    [No Abstract]   [Full Text] [Related]  

  • 54. [Renal tubular damage after rapid intravenous contrast study with iopamidol].
    Stratta P; Porcellini G; Bianchi SD; Granone A; Gatti G; Salomone M; Ragni R
    Minerva Med; 1981 Jul; 72(28):1859-62. PubMed ID: 7254634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assays for plasma complement activation by x-ray contrast media.
    Eaton S; Tsay HM; Yost F; Tweedle MF
    Invest Radiol; 1990 Jul; 25(7):789-92. PubMed ID: 2391195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnostic effectiveness and safety of currently available X-ray contrast media].
    Sergeev PV; Sviridov NK; Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 1999; (6):45-9. PubMed ID: 10714233
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of myelographic contrast-medium tolerance with psychometric testing.
    Hammeke TA; Grogan JP; Haughton VM; Pfeiffer MM; Harrington GJ; Sudilovsky A
    AJNR Am J Neuroradiol; 1985; 6(3):343-8. PubMed ID: 3923791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orbital venography: anatomy, technique, and diagnostic use.
    Dayton GO
    Trans Am Ophthalmol Soc; 1977; 75():459-504. PubMed ID: 580660
    [No Abstract]   [Full Text] [Related]  

  • 59. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up and postoperative radiculography. A radiological analysis of 640 patients.
    Castan P; Bourbotte G; Herail JP; Maurel J
    J Neuroradiol; 1977 Mar; 4(1):49-93. PubMed ID: 874539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.